4.5 Article

Cysteinyl leukotriene D4 (LTD4) promotes airway epithelial cell inflammation and remodelling

Journal

INFLAMMATION RESEARCH
Volume 70, Issue 1, Pages 109-126

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00011-020-01416-z

Keywords

Cysteinyl leukotrienes; Leukotriene D-4; Airway epithelial cells; Inflammasome; Airway inflammation; Airway remodelling

Funding

  1. University Grant Commission (UGC), Government of India
  2. UGC-BSR Senior Research Fellowship from UGC
  3. Department of Science & Technology (DST)/Science and Engineering Research Board (SERB), Government of India [SR/S2/RJN-102/2012]
  4. Department of Biotechnology, Government of India [BT/RLF/Re-entry/36/2012]

Ask authors/readers for more resources

The study found that LTD4 can induce inflammatory response in human airway epithelial cells by activating the NALP3 inflammasome, and further promote airway epithelial cells' remodeling through the TGF-beta/smad2/3-mediated pathway. Additionally, obese mice challenged with OVA showed asthma-like lung inflammation and remodeling phenotypes.
Objective Cysteinyl leukotrienes (CysLTs), a group of inflammatory lipid mediators, are found elevated in obese-asthmatic patients. Leukotriene D-4 (LTD4), a representative CysLT, is implicated in promoting lung inflammation and remodelling in allergic asthma, but its role in non-allergic asthma, especially in obese-asthmatic patients, is not known. Here, using primary human small airway epithelial cells (SAECs) we have investigated the mechanism of LTD4-induced inflammation and remodelling and assessed high proneness of obese mice to develop asthma upon challenge with allergen ovalbumin (OVA). Methods Primary human small airway epithelial cells (SAECs) were stimulated with different concentrations of LTD4 for different time intervals and various inflammatory markers were measured through cytokine array, membrane-based ELISA and Western blotting. An air-liquid interface (ALI) model of SAECs was used to study the effects of LTD4-induced remodelling in SAECs using Western blotting, H&E staining and PAS staining. Further, OVA-based murine model was used to examine the propensity of high-fat diet (HFD)-fed obese mice to develop asthma symptoms by studying the infiltration of inflammatory cells (assessed by bronchioalveolar lavage (BAL) cytology) and airway remodelling (assessed by histopathology) upon allergen exposure. Results The human primary small airway epithelial cells (SAECs) treated with LTD4 showed significant alterations in the levels of inflammatory markers such as GM-CSF, TNF-alpha, IL-1 beta, EGF and eotaxin in dose- and time-dependent manner. Further, LTD4 enhanced the activation of inflammasomes as evidenced by increased levels of NALP3, cleaved caspase-1 and IL-1 beta. LTD4 also enhanced inflammation by increasing the expression of COX-2 in SAECs. The airway remodelling markers Vimentin and Muc5AC were found elevated in ALI culture of SAECs when stimulated with LTD4, as it also increased TGF-beta levels and activation of Smad2/3 phosphorylation in SAECs. Last, sensitization and challenge of HFD-fed obese mice with OVA showed increased infiltration of inflammatory cells in BAL and enhanced levels of remodeling phenotypes like loss of cilia, mucus cell metaplasia and collagen deposition in mice lung tissues. Conclusion The results suggest that LTD4 could induce inflammatory response in human airway epithelial cell by activating NALP3 inflammasome. LTD4 could further promote airway epithelial cells' remodelling through TGF-beta/smad2/3-mediated pathway. Our in vivo results suggested that obesity predisposed the OVA challenged mice to develop lung inflammation and remodelling akin to asthma-like phenotypes during obesity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available